Overview

Dose Escalation Study of Vinpocetine in Healthy Volunteers

Status:
NOT_YET_RECRUITING
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine whether vinpocetine is safe when taken at higher doses.
Phase:
PHASE1
Details
Lead Sponsor:
Stanford University
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Treatments:
vinpocetine